Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1600
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Bio-Rad Laboratories Inc (BIO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. Bio-Rad offers its products to universities and medical schools, industrial research organizations, pharmaceutical manufacturers, government agencies, biotechnology researchers, food producers, food testing laboratories, reference laboratories, hospital and transfusion laboratories, and physician office laboratories. It markets products through direct sales force and also through a network of distributors, agents, brokers and resellers across the world. The company operates in the US, Canada, Latin America, Europe and Asia, among others. Bio-Rad is headquartered in Hercules, California, the US.

Bio-Rad Laboratories Inc Key Recent Developments

Mar 02,2020 BIO-RAD LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Feb 13,2020 Bio-Rad reports fourth-quarter and full-year 2019 financial results
Feb 04,2020 Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users
Jan 06,2020 Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bio-Rad Laboratories Inc – Key Facts
Bio-Rad Laboratories Inc – Key Employees
Bio-Rad Laboratories Inc – Key Employee Biographies
Bio-Rad Laboratories Inc – Major Products and Services
Bio-Rad Laboratories Inc – History
Bio-Rad Laboratories Inc – Company Statement
Bio-Rad Laboratories Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Bio-Rad Laboratories Inc – Business Description
Business Segment: Clinical Diagnostics
Overview
Performance
Key Stats
Business Segment: Life Science
Overview
Performance
Key Stats
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Bio-Rad Laboratories Inc – Corporate Strategy
Bio-Rad Laboratories Inc – SWOT Analysis
SWOT Analysis – Overview
Bio-Rad Laboratories Inc – Strengths
Bio-Rad Laboratories Inc – Weaknesses
Bio-Rad Laboratories Inc – Opportunities
Bio-Rad Laboratories Inc – Threats
Bio-Rad Laboratories Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Bio-Rad Laboratories Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 02, 2020: BIO-RAD LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results
Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users
Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President
Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents
Dec 23, 2019: The International Trade Commission issues final decision affirming 10X genomics infringement of three of Bio-Rad’s patents
Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack
Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results
Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results.
Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Bio-Rad Laboratories Inc, Key Facts
Bio-Rad Laboratories Inc, Key Employees
Bio-Rad Laboratories Inc, Key Employee Biographies
Bio-Rad Laboratories Inc, Major Products and Services
Bio-Rad Laboratories Inc, History
Bio-Rad Laboratories Inc, Subsidiaries
Bio-Rad Laboratories Inc, Key Competitors
Bio-Rad Laboratories Inc, Ratios based on current share price
Bio-Rad Laboratories Inc, Annual Ratios
Bio-Rad Laboratories Inc, Annual Ratios (Cont...1)
Bio-Rad Laboratories Inc, Annual Ratios (Cont...2)
Bio-Rad Laboratories Inc, Interim Ratios
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Bio-Rad Laboratories Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Bio-Rad Laboratories Inc, Performance Chart (2015 - 2019)
Bio-Rad Laboratories Inc, Ratio Charts
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Bio-Rad Laboratories Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ICICI Lombard General Insurance Company Limited:企業の戦略・SWOT・財務情報
    ICICI Lombard General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary ICICI Lombard General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • OncoSec Medical Inc (ONCS)-製薬・医療分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • A1M Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary A1M Pharma AB (A1M Pharma) is a developer of a medical application for the diagnosis and treatment of pre-eclampsia and acute renal damage. The company develops and commercializes drug candidate for the diagnosis and treatment of pre-eclampsia (pandemic poisoning) and acute renal injury. It …
  • bioMerieux SA (BIM)-医療機器分野:企業M&A・提携分析
    Summary bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiov …
  • Seminole Electric Cooperative, Inc.:発電所・企業SWOT分析
    Seminole Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Tizona Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tizona Therapeutics Inc (Tizona Therapeutics) is an immunology company which develops treatments for cancer and autoimmune disorders. Its lead product candidate anti-CD39 antibody inhibits the breakdown of excessive ATP released from dying tumor cells to immune suppressive adenosine leading …
  • ConocoPhillips (COP):石油・ガス:M&Aディール及び事業提携情報
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • If P&C Insurance AS:企業の戦略・SWOT・財務分析
    If P&C Insurance AS - Strategy, SWOT and Corporate Finance Report Summary If P&C Insurance AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Comision Federal de Electricidad-エネルギー分野:企業M&A・提携分析
    Summary Comision Federal de Electricidad (CFE) is a Mexican state owned power utility. It carries out the generation, transmission, distribution, supply and commercialization of electricity. The company generates electricity through various energy sources including thermal, hydro, coal-fired, wind, …
  • Teradata Corp (TDC):企業の財務・戦略的SWOT分析
    Teradata Corp (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Vistin Pharma AS (VISTIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies active pharmaceutical ingredients and solid dosage forms. The company’s products include opioids, an analgesics and antitussive; metformin, an API for the treatment of diabetes II; …
  • Svevind AB-エネルギー分野:企業M&A・提携分析
    Summary Svevind AB (Svevind) is a renewable energy company that plans, develops and operates land-based wind power projects of different sizes. The company’s services portfolio includes wind project planning, design, sale and electricity generation. Its projects include Gabrielsberget, Hornefors, Gr …
  • Koito Manufacturing Co Ltd:企業の戦略・SWOT・財務情報
    Koito Manufacturing Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Koito Manufacturing Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Detroit Medical Center:企業の戦略的SWOT分析
    Detroit Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • MAN SE (MAN)-エネルギー分野:企業M&A・提携分析
    Summary MAN SE (MAN) is a commercial vehicle and mechanical engineering company. It involves in designing, developing, manufacture and sale of wide range of engineering goods such as trucks, buses, diesel engines, turbo machinery, and special gear systems. The company operates production facilities …
  • Tupperware Brands Corporation:企業の戦略・SWOT・財務分析
    Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Senseonics Inc:企業の戦略的SWOT分析
    Senseonics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Dassault Systemes SA (DSY):医療機器:M&Aディール及び事業提携情報
    Summary Dassault Systemes SA (Dassault) is a 3D experience company that offers software applications and services. Dassault offers consulting services in the areas of design, deployment, support, training, and engineering services. The company serves various industries including aerospace and defens …
  • Gilead Sciences, Inc.:企業のM&A・事業提携・投資動向
    Gilead Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gilead Sciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Ardelyx Inc (ARDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company provides product portfolio such as tenapanor, RDX227675, RDX98940 and RDX013, among others. Its products are used for hyperphosphatemia in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆